Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: patent

October 2, 2023 Life sciences / Pharma applications

Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó

This year’s Nobel Prize in physiology or medicine has been awarded to Katalin Karikó and Drew Weissman for their work

Continue reading

April 4, 2023 Drug delivery / Pharma applications

Antibacterial drugs and cyclodextrin inclusion complexes: a patent review

The patents analyzed in the review used treatments based on antibiotics already on the market, natural products, and synthesized molecules

Continue reading

January 18, 2023 CD derivatives / Drug delivery / Pharma applications

New US patent for SBECD purification by CycloLab

The status of US patent application 17/344,217 (“Purification of sulfobutylated cyclodextrins with specific ion exchange resins” by CycloLab, Hungary) was

Continue reading

September 29, 2022 CD as API / Life sciences / Uncategorized

MIT scientists filed patent for HPBCD treatment in Alzheimer’s disease

Li-Huei Tsai, director of Picower Institute for Learning and Memory (Massachusetts Institute of Technology) and her coworkers recently filed a patent

Continue reading

September 20, 2022 CD derivatives / Drug delivery / Life sciences / Supramolecular systems

New US patent application on ternary CD/small guest molecule/protein interactions

Cyclolab Ltd filed a patent application (US20220282001) on cyclodextrin containing physical mixtures and inclusion complexes that show improved protein stabilizing

Continue reading

January 12, 2022 CD as API / Pharma applications

Cyclodextrin for treating lymphedema

A recent patent application of NATIONAL UNIVERSITY OF SINGAPORE claims for the treatment of lymphedema by using empty cyclodextrin (beta-cyclodextrin

Continue reading

October 28, 2021 CD as API / Drug delivery / Pharma applications / Uncategorized

METHYL-CYCLODEXTRIN FOR USE IN TREATING ENVELOPED VIRUS INFECTIONS SUCH AS SARS-CoV-2

The patent application (1) with priority date of 09. March 2020 claims that methyl bCD preferably with DS 0.7 (Crysmeb)

Continue reading

June 16, 2021 CD derivatives / Drug delivery / Pharma applications

European Patent Office upholds Curadev’s SBE-β-CD patent for new composition of matter

Yahoo Finance published: Working with Professor Steve Wicks and his team at the University of Greenwich, Curadev developed a new method for

Continue reading

June 4, 2021 Pharma applications

China National Intellectual Property Administration: A CD-complex patent case report

China National Intellectual Property Administration (CNIPA) announced the top 10 patent reexamination & invalidation cases in 2020 at its Open

Continue reading

July 15, 2020 CD as API / CD derivatives / Pharma applications

Cyclodextrin dimers to treat atherosclerotic plaques by targeting various forms of cholesterol

SENS Research Foundation (USA, California) filed a PCT patent application (WO2020142716) that was recently published. In the invention, a new class

Continue reading

Posts navigation

1 2 Next Posts»

Recent Posts

  • The background story on how the HPBCD became and orphan drug (Hommage’ a Families, Parents)
  • Cyclodextrin dimers against atherosclerosis
  • Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
  • Cyclodextrin in Vaccines
  • Special Issue “New Advances in Green Extraction Technology for Natural Products”

Tags

alpha-CD Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (17)
  • Analysis (39)
  • CD as API (231)
  • CD derivatives (287)
  • Cosmetics and toilettry (22)
  • Diagnosis (2)
  • Drug delivery (499)
  • E-ducation (59)
  • Environmental (84)
  • Events (167)
  • Food (138)
  • Gene delivery (12)
  • In Hungarian (4)
  • Life sciences (21)
  • Non-pharma applications (250)
  • Other industrial use (74)
  • Pharma applications (784)
  • Supramolecular systems (30)
  • Uncategorized (56)

Top Posts

  • Australian company pioneering Cavadextrin for regression of atherosclerosis
  • Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
  • Cyclodextrin dimers against atherosclerosis
  • BioNTech's new invention: CD as potential cryoprotectant in lipid-based RNA formulation
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrin in Vaccines
  • Workshop on Cyclodextrins, Turin 2023
  • Special Issue "New Advances in Green Extraction Technology for Natural Products"
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • EuroCD2023 concluded

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 566 other subscribers
 

Loading Comments...